These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1508400)

  • 41. Neurotransmitter amino acids in cerebrospinal fluid of patients with Alzheimer's disease.
    Jiménez-Jiménez FJ; Molina JA; Gómez P; Vargas C; de Bustos F; Benito-León J; Tallón-Barranco A; Ortí-Pareja M; Gasalla T; Arenas J
    J Neural Transm (Vienna); 1998; 105(2-3):269-77. PubMed ID: 9660105
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cerebrospinal fluid alpha-synuclein does not discriminate between dementia disorders.
    Spies PE; Melis RJ; Sjögren MJ; Rikkert MG; Verbeek MM
    J Alzheimers Dis; 2009; 16(2):363-9. PubMed ID: 19221426
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Administration of vigabatrin (gamma-vinyl-gamma-aminobutyric acid) affects the levels of both inhibitory and excitatory amino acids in rat cerebrospinal fluid.
    Halonen T; Pitkänen A; Riekkinen PJ
    J Neurochem; 1990 Dec; 55(6):1870-4. PubMed ID: 2230800
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Total tau in cerebrospinal fluid differentiates Alzheimer's disease from vascular dementia.
    Leszek J; Małyszczak K; Janicka B; Kiejna A; Wiak A
    Med Sci Monit; 2003 Nov; 9(11):CR484-8. PubMed ID: 14586274
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Cerebrospinal fluid protein tau levels in the differential diagnosis of Alzheimer's disease].
    Schonknecht P; Pantel J; Werle E; Hartmann T; Essig M; Baudendistel K; Beyreuther K; Schroder J
    Fortschr Neurol Psychiatr; 2000 Oct; 68(10):439-46. PubMed ID: 11103680
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comprehension of emotions: comparison between Alzheimer type and vascular type dementias.
    Shimokawa A; Yatomi N; Anamizu S; Ashikari I; Kohno M; Maki Y; Torii S; Isono H; Sugai Y; Koyama N; Matsuno Y
    Dement Geriatr Cogn Disord; 2000; 11(5):268-74. PubMed ID: 10940678
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The psychopathological pictures of the early stages of dementia syndromes (vasogenic and of Alzheimer's type)].
    Bidzan L
    Psychiatr Pol; 1998; 32(5):583-95. PubMed ID: 9920996
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased levels of hyaluronic acid in cerebrospinal fluid in patients with vascular dementia.
    Nägga K; Hansson O; van Westen D; Minthon L; Wennström M
    J Alzheimers Dis; 2014; 42(4):1435-41. PubMed ID: 25024336
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study.
    Andreasen N; Vanmechelen E; Van de Voorde A; Davidsson P; Hesse C; Tarvonen S; Räihä I; Sourander L; Winblad B; Blennow K
    J Neurol Neurosurg Psychiatry; 1998 Mar; 64(3):298-305. PubMed ID: 9527138
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hippocampal free amino acids in Alzheimer's disease.
    Tarbit I; Perry EK; Perry RH; Blessed G; Tomlinson BE
    J Neurochem; 1980 Nov; 35(5):1246-9. PubMed ID: 7452316
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cerebrospinal fluid from patients with dementia contains increased amounts of an unknown factor.
    White LR; Gårseth M; Aasly J; Sonnewald U
    J Neurosci Res; 2004 Oct; 78(2):297-301. PubMed ID: 15378514
    [TBL] [Abstract][Full Text] [Related]  

  • 52. No increase in cerebrospinal fluid tau protein levels in patients with vascular dementia.
    Arai H; Satoh-Nakagawa T; Higuchi M; Morikawa Y; Miura M; Kawakami H; Seki H; Takase S; Sasaki H
    Neurosci Lett; 1998 Nov; 256(3):174-6. PubMed ID: 9855368
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cerebrospinal fluid concentrations of functionally important amino acids and metabolic compounds in patients with mild cognitive impairment and Alzheimer's disease.
    Kaiser E; Schoenknecht P; Kassner S; Hildebrandt W; Kinscherf R; Schroeder J
    Neurodegener Dis; 2010; 7(4):251-9. PubMed ID: 20551690
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alpha 1-antichymotrypsin as a possible biochemical marker for Alzheimer-type dementia.
    Matsubara E; Hirai S; Amari M; Shoji M; Yamaguchi H; Okamoto K; Ishiguro K; Harigaya Y; Wakabayashi K
    Ann Neurol; 1990 Oct; 28(4):561-7. PubMed ID: 2147546
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gait disturbance of patients with vascular and Alzheimer-type dementias.
    Tanaka A; Okuzumi H; Kobayashi I; Murai N; Meguro K; Nakamura T
    Percept Mot Skills; 1995 Jun; 80(3 Pt 1):735-8. PubMed ID: 7567389
    [TBL] [Abstract][Full Text] [Related]  

  • 56. LOW specificity limits the use of the cerebrospinal fluid AB1-42/P-TAU181P ratio to discriminate alzheimer's disease from vascular dementia.
    Le Bastard N; Van Buggenhout M; De Leenheir E; Martin JJ; De Deyn PP; Engelborghs S
    J Gerontol A Biol Sci Med Sci; 2007 Aug; 62(8):923-4; author reply 924-5. PubMed ID: 17702886
    [No Abstract]   [Full Text] [Related]  

  • 57. Ventricular cerebrospinal fluid concentrations of putative amino acid transmitters in Parkinson's disease and other disorders.
    Perschak H; Amsler U; Vischer A; Siegfried J; Cuénod M
    Hum Neurobiol; 1987; 6(3):191-4. PubMed ID: 2896652
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Analysis of chiral amino acids in cerebrospinal fluid samples linked to different stages of Alzheimer disease.
    Samakashvili S; Ibáñez C; Simó C; Gil-Bea FJ; Winblad B; Cedazo-Mínguez A; Cifuentes A
    Electrophoresis; 2011 Oct; 32(19):2757-64. PubMed ID: 21983823
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Amino acid release from biopsy samples of temporal neocortex from patients with Alzheimer's disease.
    Smith CC; Bowen DM; Sims NR; Neary D; Davison AN
    Brain Res; 1983 Mar; 264(1):138-41. PubMed ID: 6133580
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of CSF biomarkers in the diagnostic work-up of mixed vascular-degenerative dementia.
    Engelborghs S; Le Bastard N
    J Neurol Sci; 2012 Nov; 322(1-2):197-9. PubMed ID: 22947896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.